Concerned health workers filed a complaint on Thursday before the Office of the Ombudsman against Undersecretary Glenn ...
Independent biopharmaceutical company Specialised Therapeutics is pleased to announce that NIKTIMVO® (axatilimab) has been approved for use in Australia by the Therapeutic Goods Administration (TGA) ...
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) ...
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...
Researchers may be closer to improving the lives of people with coronary artery disease and children born with pediatric congenital cardiovascular defects through the development of a new vascular ...
At 39, I've never had a cavity, and my doctor used to say my mouth was boring. But I was born with thin gum tissue, and my gums started to recede gradually. I had gum-graft surgery to avoid an exposed ...
For over two decades, scientists and clinicians have recognized the existence of a graft-versus-tumor effect, whose role has become increasingly important in the treatment of hematologic malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results